Chuck Rosenberg, who has been the acting administrator of the Drug Enforcement Administration since 2015, said Tuesday he’ll be leaving the job.
That means President Donald Trump will get to appoint a successor.
It also means the DEA could reverse course on a cannabis-related policy announced in August 2016 to grant more research permits to scientists who want to study marijuana.
That, along with several other policy points, has led Rosenberg to butt heads with other members of the Trump administration, The Washington Post reported.
Just last month, news broke that the Justice Department,